Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin
Alex Thompson, Scott Devine, Mike Kattan, Andrew Muir
PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2014
The funder of this project (Merck) provided support in the form of salaries for authors [SD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.